MNCM News

"The two words ‘information’ and ‘communication’ are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through." -- Sydney J. Harris

HEDIS Reporting Changes: Childhood Immunization Status and Immunizations for Adolescents

In August 2016, MNCM’s Measurement and Reporting Committee approved recommendations that further align the Childhood Immunization Status HEDIS measure with CMS’s Merit-Based Incentive Payment System (MIPS) requirements.

In the 2017 report year, MNCM will report the Childhood Immunization Status Combo 10 measure. The Childhood Immunization Status measure evaluates children’s vaccination status, as of their second birthday. Evidence and national consensus support the recommendation for children to receive all vaccines encompassed in the HEDIS Childhood Immunization Combo 10 measure. Currently, MNCM reports results for the Childhood Immunization Status Combo 3 measure. Three additional vaccines are included in Combo 10: Hepatitis A, Rotavirus, and influenza, all of which are included in state and national preventive care guidelines, both from ICSI and the USPSTF.

In the 2018 report year, MNCM will report the Immunizations for Adolescents Combo 2 measure. The Immunization for Adolescents measure evaluates adolescents’ vaccination status, as of their thirteen birthday. Evidence and national consensus support the recommendation for adolescents to receive all vaccines encompassed in the HEDIS Immunization for Adolescents Combo 2 measure. Currently, MNCM reports the Immunization for Adolescents Combo 1 measure. In the 2017 report year, the National Committee for Quality Assurance (NCQA) will introduce Combo 2 for this measure – an update that will include the HPV vaccine for males and females. In the 2018 report year, NCQA has updated their specifications for this measure to reflect the most recent guidelines for HPV vaccine, namely, children aged 11-12 receiving two doses, instead of the previously recommended three doses. The addition of the HPV vaccine is supported by state and national preventive care guidelines. With recent changes in recommendations by the US Preventive Services Task Forces (USPSTF) and NCQA’s recent update of the measure, reporting this measure as a Combo 2 allows MNCM to be completely aligned with national and local guidelines.